CS logo
small CS logo
DermEdge Research

Mississauga, Ontario, Canada
Dermatologist in Mississauga, Ontario
755 Queensway E Suite 107, Mississauga, ON L4Y 4C5

About DermEdge Research


"Dermatology clinic"
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
6
Amgen
3
Janssen Research & Development, LLC
3
Boehringer Ingelheim
2
Bristol-Myers Squibb
2
Dermira, Inc.
2
Eli Lilly and Company
2
LEO Pharma
2
BioSyntech Canada Inc.
1
Celgene
1
Fresenius Kabi SwissBioSim GmbH
1
Total Rows: 14

Clinical Trials at DermEdge Research


During the past decade, DermEdge Research conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 15 clinical trials were completed, i.e. on average, 57.7% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 11 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11114477223344440000001133222266Started TrialsCompleted Trails2015201620172018201920202021202202468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
BST-DERMON Versus Standard of Care in the Treatment of Diabetic Foot Ulcers
2007-02-01
2008-11-01
Terminated
40
Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail
2007-01-01
2008-10-01
Completed
443
A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel
2015-09-17
2017-03-17
Completed
213
MSB11022 in Moderate to Severe Chronic Plaque Psoriasis
2016-02-16
2017-12-18
Completed
443
Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis
2017-02-28
2018-02-06
Completed
78
A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris
2017-02-06
2017-12-21
Completed
744
A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris
2017-03-21
2018-04-27
Completed
748
Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)
2017-06-12
2019-08-14
Completed
794

Rows per page:

1–28 of 28

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "DermEdge Research" #1 sponsor was "Pfizer" with 6 trials, followed by "Amgen" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 14 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "DermEdge Research" #1 collaborator was "Dermira, Inc." with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 6Pfizer: 6Amgen: 3Amgen: 3Janssen Research &Development, LLC: 3Janssen Research &Development, LLC: 3Boehringer Ingelheim: 2Boehringer Ingelheim: 2Bristol-Myers Squibb: 2Bristol-Myers Squibb: 2Dermira, Inc.: 2Dermira, Inc.: 2Eli Lilly and Company: 2Eli Lilly and Company: 2LEO Pharma: 2LEO Pharma: 2BioSyntech Canada Inc.: 1BioSyntech Canada Inc.: 1Celgene: 1Celgene: 1

Created with Highcharts 11.1.0Top CollaboratorsDermira, Inc.: 1Dermira, Inc.: 1Merck KGaA,Darmstadt, Germany: 1Merck KGaA,Darmstadt, Germany: 1

Clinical Trials Conditions at DermEdge Research


According to Clinical.Site data, the most researched conditions in "DermEdge Research" are "Plaque Psoriasis" (7 trials), "Psoriasis" (7 trials), "Atopic Dermatitis" (6 trials), "Dermatitis, Atopic" (4 trials) and "Acne Vulgaris" (3 trials). Many other conditions were trialed in "DermEdge Research" in a lesser frequency.

Clinical Trials Intervention Types at DermEdge Research


Most popular intervention types in "DermEdge Research" are "Drug" (27 trials), "Other" (3 trials), "Device" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "ABP 654" (2 trials), "Abrocitinib 200 mg" (2 trials), "BMS-986165" (2 trials) and "Guselkumab" (2 trials). Other intervention names were less common.

Clinical Trials Genders at DermEdge Research


The vast majority of trials in "DermEdge Research" are 28 trials for "All" genders.

Clinical Trials Status at DermEdge Research


Currently, there are NaN active trials in "DermEdge Research". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in DermEdge Research, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in DermEdge Research, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 16Phase 3: 16Phase 2: 11Phase 2: 11Phase 1: 1Phase 1: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 19Completed: 19Active, not recruiting: 5Active, not recruiting: 5Terminated: 3Terminated: 3Recruiting: 1Recruiting: 1